ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 29, 2024 -- For adults aged 65 years and older with Alzheimer disease, the emergency department visit rate was 36.1 visits per 1,000 adults in 2020 to 2022, according to an October data brief published by the National Center for Health Statistics.
Loredana Santo, M.D., M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues describe emergency department visits by adults aged 65 years and older with Alzheimer disease and compared them to visits by adults without Alzheimer disease using data from the National Hospital Ambulatory Medical Care Survey.
The researchers found that the annual hospital emergency department visit rate by adults aged 65 years and older with Alzheimer disease was 36.1 visits per 1,000 adults during 2000 to 2020 and increased with age. Ambulance arrival was more frequent for adults with versus without Alzheimer disease (61.0 versus 34.9 percent). More emergency department visits were made by nursing home residents with versus without Alzheimer disease (29.6 versus 5.9 percent). More emergency department visits made by adults with versus without Alzheimer disease resulted in hospital admission (37.2 versus 28.6 percent).
"Among adults age 65 and older, a higher percentage of emergency department visits by adults with Alzheimer disease resulted in hospital admission," the authors write. "However, when examined across age groups, the difference was statistically significant only for visits by those ages 65 to 74."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
WEDNESDAY, July 23, 2025 -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with...
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.